More articles about Policy & Legislation

Increasing NIH funding has been a priority for Congress in recent years, despite calls from the White House to trim the agency's budget.

These lobbying efforts aim to shore up willingness among legislators to step in and halt implementation of the NCD if certain provisions remain in the final version.

At the ACLA conference this week, FDA Commissioner Gottlieb outlined his vision for the agency in the realm of LDTs.

The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.

While the President's budget proposal would slash the NIH's budget by 27 percent, the White House is seeking additional funding to bring the agency's budget to its 2017 level.

The spending deal comes amid efforts by lawmakers to avoid another government shutdown, and includes lifting the national debt limit through March 1, 2019.

The registry from the American Society for Clinical Pathology aims to eventually collect metrics on how lab services impact patient outcomes.

As gene drive research is being proposed to find a solution to infectious disease outbreaks, some organizations say we must lay an ethical groundwork for its use.

NIH officials have reopened public comments through Dec. 12 on a plan to ease access to certain categories of genomic summary results.

Attendees at the recent AMP meeting grappled with issues brought to light in a lawsuit regarding the alleged negligent misclassification of a patient's genetic variant.

A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.

The wide-ranging discussion with witnesses from Stanford, Johns Hopkins, and Editas Medicine touched on recent advances in research and questions of safety.

According to survey results presented at ASHG, most genetics experts support somatic and germline gene editing, though few favor trait enhancement.

With only one test FDA-approved for primary hrHPV screening, groups express concern about feasibility of moving away from co-testing

Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.

The biggest losers following the release of the preliminary PAMA rates may be Quest and LabCorp, analysts said today. 

Genetic counselors and patient advocates say more people are refusing genetic testing because they're uncertain of how it will impact their insurance.

The PHG Foundation's report calls for raising clinician awareness about ctDNA testing technology in order to improve patient access to targeted therapies.

The NIH is soliciting public comments on a planned update to its Genomic Data Sharing Policy that guides data management of genomic summary results.

The group is proposing women ages 30 to 65 be screened with cervical cytology every three years or receive testing for high-risk HPV every five years.

Pages

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.